Dr Dilip Surana, CMD of Micro Labs Limited, hails tariff shield as a landmark step that strengthens India’s $9 billion pharma exports to the US,... Read More
Micro Labs Limited
Dilip Surana’s rebuttal to Trump’s autism-paracetamol claim is backed by global scientific consensus and WHO’s latest clarification, reinforcing Dolo-650’s leadership in India’s pharmaceutical landscape. Dilip... Read More
Dr Dilip Surana, CMD, Micro Labs Limited featured in the prestigious Healthcare Super Brands Asia
3 min read
Healthcare Super Brands, Asia’s leading title in healthcare communications from the Pharma Leaders Group has featured Dr Dilip Surana, CMD, Micro Labs Limited for demonstrating... Read More

India–US Trade Deal Secures Lifeline for Affordable Generics – Dr Dilip Surana
Micro Labs Chief Dilip Surana Dismantles Trump’s Claim: Science Shows No Autism Risk from Paracetamol